DoW Breast Cancer, Breakthrough Award Level 3
Funds breast cancer research mature enough to run a small clinical trial, though a trial is not required at this level.
Some breast cancer ideas are ready for more than a lab bench — they are ready to be tried, carefully, in a small group of patients. This award is DoW's route for that stage of work.
It funds Funding Level 3 of the Breast Cancer Research Program's Breakthrough Award, and every application still has to address at least one FY26 BCRP overarching challenge. A small-scale clinical trial is allowed her…
Breast cancer research at BCRP Breakthrough Award Funding Level 3, addressing at least one FY26 BCRP overarching challenge, mature enough to support an optional small-scale clinical trial. The research team must include two or more breast cancer consumer advocates.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up